Geneva: The World Health Organization has announced that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after new data and studies showed no benefit.
According to the WHO recent trials showed that the anti-malaria drug does not result in the reduction of mortality of hospitalised COVID-19 patients.
“Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician,” the WHO statement said.
